The Scientific Advisory Board (SAB) is a central component of AIHTA’s quality assurance and makes an essential contribution to the further methodological development of the institute. In accordance with the Articles of Association, the board consists of five HTA experts with different specialisations who have no connection to projects in Austria. Three members are appointed on the recommendation of the shareholders, while two further members are proposed by the management.
The current members of the SAB are
- Prof. Michael Barry, NCPE: National Centre of Pharmacoeconomics (IE) – Clinical Director & Head of Department of Pharmacology
- Irina Cleemput, PhD, KCE: Belgian Healthcare Knowledge Centre (BEL) – Scientific Director
- Lonneke Koenraadt-Janssen, MSc, ZIN: National Healthcare Centre Zorginstituut Netherlands (NL) – Director of Development, Research and International Affairs
- Prof. Dr. med. Stefan Sauerland, IQWIG: Institute for Quality and Efficiency in Health Care (DE) – Head of Non-Drug Interventions Ressort
- Sophie Söderholm Werkö, PhD, SBU: Swedish Agency for Health Technology Assessment and Assessment of Social Services (SWE) – Manager International Relations & Patient Engagement
